← Leaderboards
Srividya Swaminathan
Beckman Research Institute/City Of Hope
$1,708,226
Attributed
$1,708,226
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $831.7K · FY2023–25$1M$750K$500K$250K$0
'23
'24
'25
Funding mix
By agency
NIH$1,708,226 · 2
By mechanism
R37$1,292,812 · 1
R21$415,414 · 1
Top collaborators
No co-investigators on record.
Most similar at Beckman Research Institute/City Of Hope
Same institution · by research overlap
- Xiuli Wang$2,702,470
- Ibrahim Aldoss$1,000,623
- Tanya Siddiqi$833,273
- Javier Gordon Ogembo$11,510,265
- Vu Nguyen Ngo$2,153,609
Others in their field
Other Rising Stars on “Knock-Down”
- Suma Babu · Massachusetts General Hospital$9,298,517
- Sabrina Paganoni · Massachusetts General Hospital$9,298,517
- Timothy I Richardson · Indiana University Indianapolis$3,602,073
- Osama Al Dalahmah · Columbia University Health Sciences$3,409,585
- Fouad T Chebib · Mayo Clinic Jacksonville$2,967,657
- Ming He · University Of California, San Diego$2,917,239
Research focus
Knock-DownPathologicIncidenceIn VivoMouse ModelPathogenicityHormonesImmuneAlternative SplicingIn VitroCell ProliferationLegal PatentCellsCell SurvivalApoptoticChildhoodAffectB-LymphocytesB-Lymphocyte SubsetsAutocrineAutoimmuneInduction Of ApoptosisAutoimmune DiseasesPhenotype
Grant awards (4)
Targeting the long isoform of the prolactin receptor to treat autoimmune diseases and B-cell malignancies$438,242
R37 · FY2025 · CA · contact PI
Targeting the long isoform of the prolactin receptor to treat autoimmune diseases and B-cell malignancies$416,328
R37 · FY2024 · CA · contact PI
Concurrent eradication of pathogenic plasma cells and their precursors in systemic lupus erythematosus$415,414
R21 · FY2024 · AR · contact PI
Targeting the long isoform of the prolactin receptor to treat autoimmune diseases and B-cell malignancies$438,242
R37 · FY2023 · CA · contact PI